Apoptosis induced by titanium dioxide nanoparticles in cultured murine microglia N9 cells

Chinese Science Bulletin

Volumn 54, Issue 20, 2009, Pages 3830-3836

  Li, XiaoBo ^a   Xu, ShunQing ^b   Zhang, ZhiRen ^c   Schluesener, Hermann J ^c  

^a SOUTHEAST UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; N9 cells; Nanoparticles; Titanium dioxide

Indexed keywords

MURINAE;

EID: 70449356946     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-009-0548-x     Document Type: Article

References (31)

1. Park E J, Yi J, Chung K H, et al. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett, 2008, 180: 222-229.
2. Rahman Q, Lohani M, Dopp E, et al. Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. Environ Health Perspect, 2002, 110: 797-800.
3. Yu Y, Ren W, Ren B. Nanosize titanium dioxide cause neuronal apoptosis: A potential linkage between nanoparticle exposure and neural disorder. Neurol Res, 2008, doi: 10.1179/174313208X 305391.
4. Bermudez E, Mangum J B, Wong B A, et al. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci, 2004, 77: 347-357.
5. Wang J, Liu Y, Jiao F, et al. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicology, 2008, 254: 82-90.
6. Sharma S H. Nanoneuroscience: Emerging concepts onnanoneuro toxicity and nanoneuroprotection. Nanomed, 2007, 2: 753-758.
7. Elder A, Gelein R, Silva V, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect, 2006, 114: 1172-1178.
8. Wang J, Chen C, Liu Y, et al. Potential neurological lesion after nasal instillation of TiO(2) nanoparticles in the anatase and rutile crystal phases. Toxicol Lett, 2008, 183: 72-80.
9. Kim Y S, Joh T H. Microglia, major player in the brain inflammation: Their roles in the pathogenesis of Parkinson's disease. Exp Mol Med, 2006, 38: 333-347.
10. Sharma S H, Sharma A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog Brain Res, 2007, 162: 245-273.
11. 2 particles in cultured human lymphoblastoid cells. Mutat Res, 2007, 628: 99-106.
12. Kreuter J. Nanoparticles-a historical perspective. Int J Pharm, 2007, 331: 1-10.
13. Schroder U, Sabel B A. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Res, 1996, 710: 121-124.
14. Olivier J C. Drug transport to brain with targeted nanoparticles. NeuroRx, 2005, 2: 108-119.
15. Federici G, Shaw B J, Handy R D. Toxicity of titanium dioxide nanoparticles to rainbow trout (Oncorhynchus mykiss): gill injury, oxidative stress, and other physiological effects. Aquat Toxicol, 2007, 84: 415-430.
16. Gremo F, Sogos V, Ennas M G, et al. Features and functions of human microglia cells. Adv Exp Med Biol, 1997, 429: 79-97.
17. Vamanu C I, Cimpan M R, Hol P I, et al. Induction of cell death by TiO(2) nanoparticles: Studies on a human monoblastoid cell line. Toxicol In Vitro, 2008, 22: 1689-1696.
18. Ayoub A E, Salm A K. Increased morphological diversity of microglia in the activated hypothalamic supraoptic nucleus. J Neurosci, 2003, 23: 7759-7766.
19. Armour A D, Powell H M, Boyce S T. Fluorescein diacetate for determination of cell viability in tissue-engineered skin. Tissue Eng Part C Methods, 2008, 14: 89-96.
20. Gonzalez-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci, 1999, 22: 219-240.
21. Hickman S E, Allison E K, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci, 2008, 28: 8354-8360.
22. Sasaki A, Kawarabayashi T, Murakami T, et al. Microglial activation in brain lesions with tau deposits: Comparison of human tauopathies and tau transgenic mice TgTauP301L. Brain Res, 2008, 1214: 159-168.
23. Lomer M C, Thompson R P, Powell J J. Fine and ultrafine particles of the diet: Influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc, 2002, 61: 123-130.
24. Gelis C, Girard S, Mavon A, et al. Assessment of the skin photoprotective capacities of an organo-mineral broad-spectrum sunblock on two ex vivo skin models. Photodermatol Photoimmunol Photomed, 2003, 19: 242-253.
25. Wang B, Feng W, Zhu M, et al. Neurotoxicity of low-dose repeatedly intranasal instillation of nano- and submicron-sized ferric oxide particles in mice. J Nanoparticle Res, 2008, 11: 41-53.
26. Wang M L, Tuli R, Manner P A, et al. Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res, 2003, 21: 697-707.
27. Osano E, Kishi J, Takahashi Y. Phagocytosis of titanium particles and necrosis in TNF-alpha-resistant mouse sarcoma L929 cells. Toxicol In Vitro, 2003, 17: 41-47.
28. Darzynkiewicz Z, Juan G, Li X, et al. Cytometry in cell necro-biology: analysis of apoptosis and accidental cell death (necrosis). Cytometry, 1997, 27: 1-20.
29. Cimpan M R, Cressey L I, Skaug N, et al. Patterns of cell death induced by eluates from denture base acrylic resins in U-937 human monoblastoid cells. Eur J Oral Sci, 2000, 108: 59-69.
30. Wang J, Zhou G, Chen C, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration, Toxicol Lett, 2007, 168: 176-185.
31. Chen L, Yokel R A, Hennig B, et al. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J Neuroimmune Pharmacol, 2008, 3: 286-295.